By integrating these therapies into comprehensive care plans, we can provide patients with holistic solutions that address their needs from multiple angles
Your doctor can help adjust dosing, manage side effects, and monitor your overall health
In Phase II trials: Efinopegdutide (Merck/Johnson & Johnson/Hanmi Harma), VK2735 (Viking Therapeutics), BGM0504 (BrightGene), Pemvidutide (Altimmune/Spitfire Pharma), AMG133 (Amgen), Dapiglutide (Zealand Pharma), etc
Expanding Product Selection The peptide industry continues evolving rapidly, and researchers often require access to emerging compounds and established research products
An IMC registered Doctor reviews everything and, if youre approved, your treatment plan begins
Sections outlining potential risks and benefits